Tolero Pharmaceuticals doses first patient in Phase II Zella 202 study
Myeloblasts with Auer rods seen in Acute Myeloid Leukemia (AML), advanced stage. Credit: Paulo Henrique Orlandi Mourao.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more